SCHEMBL20051311

SCHEMBL20051311

O=[SH](=O)c1cnc2ccoc2c1NC1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.38
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PDE4B Q07343 1/20 0.33
ATM Q13315 1/20 0.33
ATR Q13535 1/20 0.33
HCAR3 P49019 1/20 0.33
GAA P10253 2/20 0.33
PDGFRB P09619 2/20 0.32
PDGFRA P16234 2/20 0.32
ELANE P08246 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
PRKAB2 O43741 1/20 0.32
PRKAG1 P54619 1/20 0.32
PRKAA2 P54646 1/20 0.32
PRKAA1 Q13131 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20051446 0.80 IRAK4 (0.40) IRAK4KDM4EALDH1A1L3MBTL1PDE4B
SCHEMBL24023125 0.80 IRAK4 (0.42) IRAK4KDM4EALDH1A1L3MBTL1GAA
SCHEMBL21187403 0.70 IRAK4 (0.69) IRAK4ALDH1A1CYP3A4
SCHEMBL22764057 0.68 MKNK1 (0.38) IRAK4
SCHEMBL22767580 0.66 CDK2 (0.36) IRAK4HCAR3GAA
SCHEMBL30822849 0.63 IRAK4 (0.37) IRAK4
SCHEMBL21286732 0.63 IRAK4 (0.37) IRAK4
SCHEMBL20273951 0.62 KMT2A (0.47) IRAK4KDM4E
SCHEMBL3712626 0.58 IRAK4 (0.44) IRAK4KDM4ELRRK2
SCHEMBL15655160 0.56 PDE4B (0.44) IRAK4KDM4EALDH1A1PDE4BGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3509591-B1 NOVEL JAK1 SELECTIVE INHIBITORS AND USES THEREOF HIGHLIGHTLL PHARMACEUTICAL HAINAN CO LTD (CN) 2021-11-17 EP disclosed
WO-2018067422-A1 NOVEL JAK1 SELECTIVE INHIBITORS AND USES THEREOF LIANG CONGXIN (US) 2018-04-12 WO disclosed